Vaginal Fungi Infections Treatment Market
- 2026 年市場規模
- USD 1,347.5 Mn
- 2033 年預估規模
- USD 1,935.9 Mn
- 年複合成長率 CAGR
- 5.4%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Vaginal Fungi Infections Treatment Market, By Drug Type (Fluconazole, Nystatin, Flucytosine, Others), By Route of Administration (Oral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
A vaginal yeast infection is a fungal infection that causes irritation, discharge, and intense itchiness of the vagina and the vulva — the tissues at the vaginal opening. Vaginal fungi infection is also known as vaginal yeast infection, vulvovaginal candidiasis, candidal vaginitis or vaginal candidiasis, and it the second most common type of vaginal infection in the U.S., according the Centers for Disease Control and Prevention.
Market Dynamics
Rising incidence of vaginal fungi infections are driving vaginal fungi infections treatment market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), 2018, around 1.4 million outpatient visits occur for vaginal candidiasis every year in the U.S. Moreover, according to an article published in Multidisciplinary Digital Publishing Institute (MDPI) in February 2020, Vulvovaginal candidiasis (VVC) is the most prevalent human candidal infection and nearly 75% women across the globe are affected by it least once in their lifetime. Furthermore, according to the same source, around 8% women across the globe suffer from Recurrent Vulvovaginal Candidiasis (RVVC).
However, alternative therapies for vaginal fungi infections treatment can hinder the market growth. For instance, Nutrablast, a dedicated company in the dietary supplement and personal care offers Tea Tree Suppositories for vaginal fungi infections treatment. The product is natural tea tree oil to provide a balanced vaginal environment.
Key features of the study
• This report provides in-depth analysis of the global vaginal fungi infections treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global Vaginal Fungi Infections Treatment Market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study are Pfizer Inc., Bausch Health Companies Inc, ANI Pharmaceuticals, Inc., Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Unique Pharmaceuticals, PEPTONIC medical AB, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, and SCYNEXIS, Inc.
• Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
• The global Vaginal Fungi Infections Treatment Market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vaginal fungi infections treatment market.
Market Segmentation
• By Drug Type (Revenue, USD Mn, 2021-2033)
o Fluconazole
o Nystatin
o Flucytosine
o Others
• By Route of Administration (Revenue, USD Mn, 2021-2033)
o Oral
o Topical
• By Distribution Channel (Revenue, USD Mn, 2021-2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies.
• By Region (Revenue, USD Mn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Competitive Landscape
o Pfizer Inc.
o Bausch Health Companies Inc
o ANI Pharmaceuticals, Inc.
o Hikma Pharmaceuticals Plc
o Lupin Limited, Mycovia Pharmaceuticals, Inc.
o Glenmark Pharmaceuticals Limited
o Unique Pharmaceuticals
o PEPTONIC medical AB
o Aurobindo Pharma Limited
o Reddy's Laboratories
o SCYNEXIS, Inc.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Pipeline Analysis
o Reimbursement Scenario
o Epidemiology
o Pest Analysis
o Regulatory Scenario
o New Product Launches
o Collaborations and Agreements
o Market Trends
4. Global Vaginal Fungi Infections Treatment Market, By Drug Type, 2021– 2033, (US$ Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Fluconazole
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021– 2033, (US$ Mn)
o Nystatin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021– 2033, (US$ Mn)
o Flucytosine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021– 2033, (US$ Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021– 2033, (US$ Mn)
5. Global Vaginal Fungi Infections Treatment Market, By Route of Administration, 2021– 2033, (US$ Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021– 2033, (US$ Mn)
o Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021– 2033, (US$ Mn)
6. Global Vaginal Fungi Infections Treatment Market, By Distribution Channel, 2021– 2033, (US$ Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021– 2033, (US$ Mn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021– 2033, (US$ Mn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021– 2033, (US$ Mn)
7. Global Vaginal Fungi Infections Treatment Market, By Region, 2021– 2033, (US$ Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
o North America
Market Size and Forecast, By Drug Type, 2021– 2033, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2021– 2033, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2021– 2033, (US$ Mn)
Market Size and Forecast, By Country, 2021– 2033, (US$ Mn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Drug Type, 2021– 2033, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2021– 2033, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2021– 2033, (US$ Mn)
Market Size and Forecast, By Country, 2021– 2033, (US$ Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Drug Type, 2021– 2033, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2021– 2033, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2021– 2033, (US$ Mn)
Market Size and Forecast, By Country, 2021– 2033, (US$ Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Drug Type, 2021– 2033, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2021– 2033, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2021– 2033, (US$ Mn)
Market Size and Forecast, By Country, 2021– 2033, (US$ Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Market Size and Forecast, By Drug Type, 2021– 2033, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2021– 2033, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2021– 2033, (US$ Mn)
Market Size and Forecast, By Country, 2021– 2033, (US$ Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Drug Type, 2021– 2033, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2021– 2033, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2021– 2033, (US$ Mn)
Market Size and Forecast, By Country/Region, 2021– 2033, (US$ Mn)
o South Africa
o Central Africa
o North Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
Pfizer Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Bausch Health Companies Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
ANI Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Hikma Pharmaceuticals Plc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Lupin Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Mycovia Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Glenmark Pharmaceuticals Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Unique Pharmaceuticals
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
PEPTONIC medical AB
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Aurobindo Pharma Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Reddy's Laboratories
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
SCYNEXIS, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
Browse 37 market data tables and 25 figures on Vaginal Fungi Infections Treatment Market” - Global forecast to 2033
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們